Emdutos to Distribute VivaScope® Devices in Brazil
Equipmed to Distribute VivaScope® Devices in Australia and New Zealand
ROCHESTER, N.Y. and BOSTON, Sept. 5, 2013 (GLOBE NEWSWIRE) -- Caliber Imaging & Diagnostics (Caliber I.D.), formerly Lucid, Inc. (LCDX), has added two new distributors for its platform of VivaScope® confocal microscopes. Emdutos Industria e Comercio Ltda will distribute the VivaScope® devices in the Brazilian market. Equipmed will distribute the VivaScope® devices in the Australian and New Zealand markets. VivaScope® is registered in Brazil with Agencia Nacional de Vigilancia Sanitaria (ANVISA) and in Australia with the Therapeutic Goods Administration.
The FDA-cleared VivaScope® cellular imaging devices provide patients the option of a painless, noninvasive optical skin biopsy in lieu of expensive and painful traditional skin biopsy.
L. Michael Hone, Chief Executive Officer of Caliber I.D., said, "As Caliber I.D. seeks to strengthen awareness of VivaScope® technology worldwide, it is vital that we continue to expand into new markets. We are therefore delighted to partner with Emdutos and Equipmed. Both Brazil and Australia/New Zealand are potentially major markets for our company as the incidences of malignant skin cancers in these countries are among the highest in the world. We look forward to working with both companies as they introduce physicians to the power and versatility of the VivaScope® line of products."
Luiz Lamardo Jr., Chief Executive Officer of Emdutos, said, "Brazil represents a high-potential opportunity for VivaScope®. The country has more than 6,000 dermatologists, with practitioners and medical facilities investing in new technologies. We are excited about adding VivaScope® to our line of products and we are confident we will develop a collaborative and integrated partnership in the long term. We are proud to work with Caliber I.D. in the upcoming years."
Stene Marshall, Chief Executive Officer of Equipmed, said, "Equipmed is focused on a vision of dermatology into the future. We see that VivaScope® devices will provide physicians with valuable information when it comes to examining the skin to aid with more accurate diagnosis of skin cancer, including melanoma. Ultimately this will benefit patients in Australia and New Zealand. We are excited to be adding Caliber's products to our portfolio."
About Emdutos Industria e Comercio Ltda
Headquartered in Sao Paulo, Brazil, Emdutos is focused on marketing health products in the dermatology, urology, podiatry, aesthetic medicine and veterinary markets. Its customers are professionals who require management of skin images (including auxiliary resources for assessing the risk of malignancy of lesions), cryosurgery and skin lesions that may be treated on an outpatient basis.
Equipmed's cosmeceutical, dermatological, disinfection and aesthetic equipment uses the latest, cutting-edge technology, and is backed by Synergy of Solutions expert training, marketing and equipment maintenance support, designed to help you deliver real results and build on proven success. Equipmed has been a leading independent distributor of equipment for the cosmetic, dermatological, disinfection and cardiological industries since 1976. The company sources a range of brand names and products, picking the very best available from leading manufacturers. With in-depth knowledge of this market, Equipmed has also sourced and developed its own range of solutions, including Dermapen™, Sphere Technologies and many more.
About Caliber Imaging & Diagnostics
Caliber Imaging & Diagnostics' platform of products offer increased productivity from the research laboratory to the doctor's office or the surgeon's operating room. Caliber I.D.'s platform of products provide precise accuracy, consistent reliability, and online backup that all combine to lead to better patient care. For more information about Caliber I.D. and its products, please visit www.caliberid.com.
VivaScope® is a registered trademark of Caliber Imaging & Diagnostics.
This press release contains "forward looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes," "assumes" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved and actual results may differ materially from our beliefs or expectations due to financial, economic, business, regulatory and other factors or conditions affecting us or our industry in general, as well as more specific risks and uncertainties facing us, such as those set forth in the Risk Factors section of the Forms 10-Q and 10-K filed by us with the Securities and Exchange Commission.
CONTACT: Richard Pulsifer Chief Financial Officer (617) 348-9821 Investor Relations: Dian Griesel Inc. Cheryl Schneider (212) 825-3210 email@example.com Public Relations: Dian Griesel Inc. Susan Forman or Laura Radocaj (212) 825-3210 firstname.lastname@example.org email@example.comSource:Caliber Imaging & Diagnostics, Inc.